Myeloablative, but not Reduced-Intensity, Conditioning Overcomes the Negative Effect of Flow-Cytometric Evidence of Leukemia in Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Myeloablative, but not Reduced-Intensity, Conditioning Overcomes the Negative Effect of Flow-Cytometric Evidence of Leukemia in Acute Myeloid Leukemia

Published:2016-04 Issue:4 Volume:22 Page:669-675
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Ustun Celalettin,Courville Elizabeth L.,DeFor Todd,Dolan Michelle,Randall Nicole,Yohe Sophia,Bejanyan Nelli,Warlick Erica,Brunstein Claudio,Weisdorf Daniel J.,Linden Michael A.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference39 articles.

1. Umbilical cord blood transplantation outcomes in acute myelogenous leukemia/myelodysplastic syndrome patients aged >/=70 years;Sandhu;Biol Blood Marrow Transplant,2015

2. To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century;Ustun;Bone Marrow Transplant,2013

3. Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a Center for International Blood and Marrow Transplant Research-Eurocord analysis;Weisdorf;Biol Blood Marrow Transplant,2014

5. Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: a comparative clinical analysis;Flynn;Am J Hematol,2007

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival after allogeneic transplantation according to pretransplant minimal residual disease and conditioning intensity in patients with acute myeloid leukemia;Frontiers in Oncology;2024-05-02

2. Measurable Residual Disease Detection in Acute Myeloid Leukemia: Current Challenges and Future Directions;Biomedicines;2024-03-07

3. MRD positivity was the poor prognostic factor for adverse-risk AML patients with allogeneic hematopoietic stem cell transplantation: a multicenter TROPHY study;Blood Cancer Journal;2024-01-17

4. Engineering the best transplant outcome for high-risk acute myeloid leukemia: the donor, the graft and beyond;Cytotherapy;2023-12

5. Targeting apoptosis dysregulation in myeloid malignancies - The promise of a therapeutic revolution;Blood Reviews;2023-11